ACT-293987 in Pulmonary Arterial Hypertension (Q63832723)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ACT-293987 in Pulmonary Arterial Hypertension |
clinical trial |
Statements
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension (English)
0 references
1 December 2009
0 references
1 February 2021
0 references
670
0 references
18 year
0 references